Trials / Completed
CompletedNCT01040741
Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
A Prospective Observational Study of Safety and Occurrence of Influenza-like Illness Following Administration of Adjuvanted Swine Origin A(H1N1) Pandemic Subunit Vaccine Focetria
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,284 (actual)
- Sponsor
- Novartis Vaccines · Industry
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Accepted
Summary
This is an observational safety study of a prophylactic use of Flu Egg Derived Adjuvanted Swine Origin A(H1N1) Vaccine in subjects 6 months of age and older. Subjects may receive either 1 or 2 doses: children and elderly will receive 2 doses and adults will receive either 1 or 2 doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-intervention observational study | Non-intervention observational study |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2009-12-30
- Last updated
- 2011-10-05
Locations
14 sites across 2 countries: Argentina, Netherlands
Source: ClinicalTrials.gov record NCT01040741. Inclusion in this directory is not an endorsement.